|
Sept. 23 (Bloomberg) -- Margaret Hamburg, commissioner of the Food
and Drug Administration, talks with Bloomberg's Melissa Long and
Michael Waldholz about the FDA's decision to restrict the use of
GlaxoSmithKline Plc's Avandia. Avandia, once the world's
best-selling diabetes drug, will be withdrawn in Europe and
restricted in the U.S. after a three-year review of the medicine's
heart risks. (Source: Bloomberg)
|